Global Cancer Diagnostic Market Set to Soar Past USD 30.23 Billion by 2030

The global Cancer Diagnostic market size is expected to reach USD 30.23 billion by 2030 and exhibit a CAGR of 5.3% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing prevalence of cancer worldwide, necessitating early and accurate diagnostic methods. Advancements in technology, such as genomic and proteomic profiling, contribute to the development of more unique and personalized diagnostic tools.

Westford USA, Feb. 07, 2024 (GLOBE NEWSWIRE) — According to SkyQuest’s latest worldwide research of the Cancer Diagnostic market, the Integration of artificial intelligence in diagnostic approaches is another extremely good fashion, streamlining analysis and improving diagnostic accuracy. The emphasis on comprehensive cancer screening packages and a surge in studies and improvement sports similarly make contributions to the marketplace’s boom, fostering innovation in diagnostic methodologies, are the trends that are a useful resource in the marketplace’s boom.

Browse in-depth TOC on “Cancer Diagnostic Market”

  • Pages – 2157
  • Tables – 149
  • Figures – 78

Cancer diagnostics contain the identity and characterization of cancerous cells or tumors inside the body. Utilizing numerous techniques which include imaging, biopsies, and molecular assessments, it targets to locate most cancers early, decide its type and stage, enabling timely and targeted remedy techniques for progressing affected person effects.

Prominent Players in Cancer Diagnostic Market

  • Roche
  • Abbott Laboratories
  • Siemens Healthcare
  • Hologic
  • Becton Dickinson (BD)
  • Beckman Coulter
  • Illumina
  • bioMérieux
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Danaher Corporation
  • PerkinElmer
  • Sysmex Corporation
  • DiaSorin
  • Bio-Rad Laboratories
  • Exact Sciences
  • Myriad Genetics
  • Guardant Health
  • Foundation Medicine

Get a sample copy of this report:

Molecular Diagnostic Tests Demand to Grow Substantially in Future

Growing emphasis on precision medicine and personalized treatment approaches. Molecular diagnostic tests, inclusive of DNA sequencing and genetic profiling, offer specific insights into the genetic make-up of tumors, enabling centered healing procedures. Advancements in molecular technology make a contribution to multiplied diagnostic accuracy.

Screening is Leading Application Segment Owing to Rise in Cancer Cases

In terms of utility, Increasing emphasis on early cancer detection for powerful treatment and stepped forward patient effects. Growing focus and implementation of cancer screening programs globally. Advances in screening technology, inclusive of imaging and blood tests, make a contribution to massive adoption.

Browse summary of the report and Complete Table of Contents (ToC):

North America is Dominating Market Owing to Advent of Robot Research Activities

Region-wise, North America is certainly one of the biggest growing markets and has properly-installed healthcare infrastructure and access to advanced diagnostic technologies. High prevalence of most cancer instances and a proactive method to cancer screening and early detection. Robust research and development activities and a favorable regulatory environment.

A recent report thoroughly analyzes the major players operating within the Cancer Diagnostic market. This comprehensive evaluation has considered several crucial factors, such as collaborations, mergers, innovative business policies, and strategies, providing invaluable insights into the key trends and breakthroughs in the market. Additionally, the report has carefully scrutinized the market share of the top segments and presented a detailed geographic analysis. Finally, the report has highlighted the major players in the industry and their ongoing endeavors to develop innovative solutions that cater to the ever-increasing demand for Cancer Diagnostics.

Speak to Analyst for your custom requirements:

Key Developments in Cancer Diagnostic Market

  • In January 2024, Roche is set to pay $295 million as the acquisition price upon the final touch of the transaction. Additionally, an extra fee of up to $55 million can be made to reimburse LumiraDx for the finances expended in supporting the point-of-care diagnostics platform commercial enterprise until the deal concludes.

Key Questions Answered in Cancer Diagnostic Market Report

  • What specific growth drivers are projected to impact the market during the forecast period?
  • Can you list the top companies in the market and explain how they have achieved their positions of influence?
  • In what ways do regional trends and patterns differ within the global market, and how might these differences shape the market’s future growth?

Related Reports in SkyQuest’s Library:

Global Next Generation Sequencing Market

Global 3D Cell Culture Market

Global Synthetic Biology Market

Global Biopharmaceutical Analytical Testing Services Market

Global Influenza Diagnostics Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.


1 Apache Way, Westford, Massachusetts 01886


USA (+1) 617-230-0741


LinkedIn Facebook Twitter

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.